Bausch Health Companies Inc
BHC
Market Cap$3.05B
Close$
$12.03
44.6% upside
Current Fair Value
44.6% upsideUndervalued by 44.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.05 Billion |
|---|---|
| Enterprise Value | $24.12 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.62 |
| Beta | 0.77 |
| Outstanding Shares | 367,900,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -83.37 |
|---|---|
| PEG | -30.53 |
| Price to Sales | 0.35 |
| Price to Book Ratio | -8.32 |
| Enterprise Value to Revenue | 2.62 |
| Enterprise Value to EBIT | -20.47 |
| Enterprise Value to Net Income | 479 |
| Total Debt to Enterprise | 0.9 |
| Debt to Equity | -18.43 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bausch Health Companies Inc
21,100 employeesBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter ...